* USANA Health Sciences Inc USNA.N USNA.K is expected
to show
a fall in quarterly revenue when it reports results on October
25.
* The Salt Lake City Utah-based company is expected to
report a
10.4% decrease in revenue to $245.95 million from $274.35
million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for USANA Health
Sciences Inc
is for earnings of 92 cents per share.
* The current average analyst rating on the shares is "sell"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for USANA
Health
Sciences Inc is $55, below its last closing price of $56.69.
This summary was machine generated October 21 at 20:13 GMT. All
figures in US dollars unless otherwise stated